Enzon Pharmaceuticals, Inc. (ENZN) - NASDAQ
  • Apr. 23, 2013, 6:38 PM
    Enzon Pharmaceuticals (ENZN) declares special dividend of $1.60/share. For shareholders of record May 07. Payable June 04. Ex-div date May 03. (PR)
    | Apr. 23, 2013, 6:38 PM | 8 Comments
  • Nov. 29, 2012, 5:34 PM
    Enzon Pharmaceuticals (ENZN) declares special dividend of $2.00/share. For shareholders of record Dec 10. Payable Dec 21. Ex-div date Dec 06. (PR)
    | Nov. 29, 2012, 5:34 PM
Company Description
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. The company engages in the research and development of innovative therapeutics for cancer patients with high unmet medical needs. Its drug-development programs utilize two platforms such as customized PEGylation linker technology and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States